JCOGO_ASCO Profile Banner
JCO Global Oncology Profile
JCO Global Oncology

@JCOGO_ASCO

Followers
13K
Following
616
Statuses
2K

Cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources. Part of @JCO_ASCO family of journals.

Joined January 2016
Don't wanna be here? Send us removal request.
@JCOGO_ASCO
JCO Global Oncology
1 day
Forecasting Asparaginase Need and Cost for Childhood Cancer Using ACCESS FORxECAST: #pedonc
0
0
0
@JCOGO_ASCO
JCO Global Oncology
2 days
Survival and its Predictors among Patients Receiving Transarterial Chemoembolization for Hepatocellular Carcinoma in Ethiopia: A Six-year Follow-up Study #HCC
0
0
0
@JCOGO_ASCO
JCO Global Oncology
2 days
Treatment and Outcomes of #PancreaticCancer in Armenia: Retrospective Study From Resource Limited Settings #pancsm
0
0
0
@JCOGO_ASCO
JCO Global Oncology
2 days
Oral Cyclophosphamide for Patients with Metastatic Castration Resistant #ProstateCancer in a Scenario of Limited Healthcare Resources: #pcsm
1
1
1
@JCOGO_ASCO
JCO Global Oncology
3 days
The Landscape of Global Pediatric Oncology Publications: A Cross-Sectional Analysis #pedonc, #childhoodcancer
0
1
5
@JCOGO_ASCO
JCO Global Oncology
4 days
Conducting Clinical Research in Low Research Resource Countries: Lessons Learned from the International Registry of Men with Advanced Prostate Cancer (IRONMAN) Study in Nigeria. @opeyemibolajok2 #prostatecancer #cancerresearch Read the full study:
0
1
2
@JCOGO_ASCO
JCO Global Oncology
5 days
Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report from the LACOG Sarcoma Group. #rarecancer #sarcoma Read the full study:
0
0
1
@JCOGO_ASCO
JCO Global Oncology
5 days
#JCOGO officially welcomes @kvanloonmd as our newest Editor-in-Chief. Welcome Dr. Van Loon!
Tweet media one
1
4
17
@JCOGO_ASCO
JCO Global Oncology
9 days
Extension for Community Healthcare Outcomes - Palliative Care in Africa and Advanced Cancer Patients’ Quality of Life, Symptom Distress, Patients’ Experience, Satisfaction, and Caregiver Distress: #QoL #PallOnc
0
0
1
@JCOGO_ASCO
JCO Global Oncology
9 days
Survival Outcomes for Adolescent and Young Adults with Cancer in Low-and-Middle Income Countries: A Systematic Review #ayacsm #survonc
0
1
1
@JCOGO_ASCO
JCO Global Oncology
9 days
Impact of the COVID-19 Pandemic on #BreastCancer Patient Care: Results from a Tertiary Care Center in Lebanon: #bcsm
0
0
1
@JCOGO_ASCO
JCO Global Oncology
10 days
Multi-centric cross-sectional survey to assess the variation of fractionation strategies used in the management of head and neck cancers in the Asian region (INNOCENCE-ASIA) #headandneckcancer #cancerresearch #hncsm Read the full study:
0
0
0
@JCOGO_ASCO
JCO Global Oncology
11 days
Proposals for the Implementation of a Multidimensional Platform that Allows the Advancement of Oncology Nursing in the Latin American Environment (The INCREASE Proposal): #OncTwitter
0
0
0
@JCOGO_ASCO
JCO Global Oncology
12 days
The Frequency and Impact of Cmmrd in High-Grade Glioma Patients, A Retrospective Analysis Of 7 Years in Pakistan; An Irrdc Study: #Glioma
0
0
1
@JCOGO_ASCO
JCO Global Oncology
16 days
Efficacy and Safety of Short Intravenous Hydration for Preventing Nephrotoxicity from High-Dose Cisplatin: A Randomized, Open-Label, Phase 2 Trial:
0
0
1
@JCOGO_ASCO
JCO Global Oncology
16 days
High Prevalence of Malnutrition in Geriatric Patients With Solid Organ Cancer–An Institutional Study: #gerionc
0
0
0
@JCOGO_ASCO
JCO Global Oncology
19 days
Elevating #CancerCare Standards Worldwide: An Analysis of Global Initiatives and Progress. #healthequity #healthcaredisparities ➡️
0
0
1
@JCOGO_ASCO
JCO Global Oncology
19 days
Targeted Next-Generation Sequencing of Cell-Free DNA to Detect MYC-Immunoglobulin Translocation and Epstein Barr Virus DNA in Plasma of #BurkittLymphoma Cases in East Africa: #lymsm
0
0
1
@JCOGO_ASCO
JCO Global Oncology
19 days
An Observational Study of Best Supportive Care (BSC) With or Without Oral Capecitabine (X) in Patients with Metastatic Carcinoma Gallbladder at a Tertiary Centre in India: #gicsm
0
0
0
@JCOGO_ASCO
JCO Global Oncology
22 days
Bilateral Mediastinal Lymphadenectomy is Associated With Potential Survival Advantages in Patients With Solid-Dominant Stage I #NSCLC Who Undergo Anatomic Lung Resection: #lcsm
0
0
2